ERBI and London Biotechnology Network announce merger
ERBI, the not-for-profit membership company for international life science and healthcare companies, and the London Biotechnology Network (LBN), the business network for London-based life science organisations, have announced a merger. The combined group will operate under the ERBI name, until the launch of a new identity at the ERBI Annual Conference on 2nd June.
The new organisation combines ERBI’s 350+ members with LBN’s network of over 400 organisations across a wide range of life science industry sectors. The network represents a powerhouse of commercial, clinical and academic interests with at least 60% of the UK’s life science industry base, four of the UK’s five Academic Health Science Centres and three of the world’s top six universities. The merger recognises that the Cambridge-London network is an international life science “super cluster”.
The newly merged organisation continues to have offices in both Cambridge and London, with Harriet Fear as CEO. Tony Jones becomes Director, Business Development and a member of the senior management team. Meetings and events will continue in both London and Cambridge.
Other news from the department business & finance
